About Bruker Corp
- Industry: Life Sciences Tools & Services
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.bruker.com/
Frequently Asked Questions
What is the 52-week range for BRKR?
The 52-week high is $66.9808 and the 52-week low is $32.37.
What is the P/E ratio for BRKR?
The P/E ratio data is currently unavailable.
What is the dividend yield for BRKR?
The indicated annual dividend yield is 0.30%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -2.93%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -2.03%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.91.
Analyst Recommendation Trends
Wall Street analyst consensus for BRKR over the last few months:
Latest BRKR News
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel
QGEN expands its U.S. QIAstat-Dx portfolio with an FDA-cleared panel that detects gram-negative bacteria and resistance markers in about one hour.
Guggenheim Maintains Buy on Bruker, Raises Price Target to $72
Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price target from $70 to $72.
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $80
Leerink Partners analyst Puneet Souda maintains Bruker (NASDAQ:BRKR) with a Outperform and raises the price target from $60 to $80.
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research
SINGAPORE, September 28, 2026--At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis. Multi-enzyme dia-PASEF provides additional peptide information for investigations of isoforms and proteoforms, while ProteoScape workflows connect PASEF d
Bruker Sees AI-Fueled Semiconductor Demand, Targets Critical Q4 Revenue Rebound
Bruker (NASDAQ:BRKR) CFO Gerald Herman said the company’s second-quarter results reflected stronger-than-expected organic order bookings and earnings per share, while revenue came in later than anticipated. He attributed the revenue timing primarily to a mixed demand environment and shipment timing,
Bruker Corporation (BRKR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Bruker Corporation (BRKR) Bank of America Global Healthcare Conference 2026 September 22, 2026 6:45 AM EDTCompany ParticipantsGerald Herman - Executive VP...
Is Bruker (BRKR) Using Flagship Academic NMR Deals To Deepen Its High-End Moat?
Bruker Corporation previously announced a multi-system order worth more than US$6.00 million from the University of California, Berkeley to equip the Pines Magnetic Resonance Center with next-generation high-field NMR instrumentation, including an AV NEO-X 800 MHz spectrometer with a cryogenically cooled MAS CryoProbe and multiple supporting systems, scheduled for delivery in 2027. This large academic investment highlights how Bruker’s advanced NMR platforms are being embedded in...
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley
BERKELEY, Calif., September 21, 2026--Bruker Corporation (Nasdaq: BRKR) today announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz–class instrumentation. These capabilities strengthen research in chemistry, materials science, structural biology, and related fields across UC Berkeley
Bruker Wins Major UC Berkeley Order For Advanced Research Systems
Bruker Corporation (NASDAQ:BRKR) today announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center.
Bruker Corporation (BRKR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Bruker Corporation (BRKR) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 10:45 AM EDTCompany ParticipantsFrank Laukien -...
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent, Cipher and others post gains.
Why Bruker (BRKR) Stock Is Falling Today
Shares of scientific instrument company Bruker (NASDAQ:BRKR) fell 6.3% in the afternoon session after UBS initiated coverage on the stock with a Neutral rating and a $65 price target.
UBS Maintains Neutral on Bruker, Raises Price Target to $65
UBS analyst Dan Leonard maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $45 to $65.
Bruker Corporation (BRKR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Bruker Corporation (BRKR) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsFrank Laukien - Chairman, CEO &...
Bruker Corporation to Present at Upcoming Investor Conferences
BILLERICA, Mass., September 08, 2026--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences:
Bruker (BRKR) Wagers On Fusion Energy While Wall Street Waits
On September 4, Bruker (NASDAQ:BRKR) said its energy and supercon technologies unit, Bruker Energy & Supercon Technologies (or BEST), had struck a supply collaboration with Luvata Materials & Solutions to scale up production of RRP superconductors for magnetic confinement fusion. The deal lands right as governments and private developers from Europe to South Korea race […]
BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion
HANAU, Germany, September 04, 2026--Bruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (Nasdaq: BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) today announced a strategic collaboration to support the rapidly growing demand for superconducting materials and technologies required by next-generation magnetic confinement fusion power demonstration plant projects worldwide.
Bruker, Luvata Team Up To Boost Superconductor Supply For Fusion Power Projects
Bruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (NASDAQ:BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) today announced a strategic collaboration
Why Is Bruker (BRKR) Up 12.5% Since Last Earnings Report?
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-15 | Munch Mark | -2,000 | - | - |
| 2026-09-15 | Munch Mark | -2,000 | $52.87 | $105,740 |
| 2026-09-15 | Munch Mark | +2,000 | $22.19 | $44,380 |
| 2026-08-17 | Pusch Wolfgang | -3,473 | $56.9 | $197,614 |
| 2026-08-15 | Pusch Wolfgang | +2,529 | - | - |
| 2026-08-15 | Pusch Wolfgang | +3,120 | - | - |
| 2026-08-15 | Bures Thomas | +4,035 | - | - |
| 2026-08-15 | Srega Juergen | +13,698 | - | - |
| 2026-08-15 | Srega Juergen | +16,898 | - | - |
| 2026-08-15 | Prause Burkhard | +2,678 | - | - |
| 2026-08-15 | Prause Burkhard | +3,303 | - | - |
| 2026-08-15 | Munch Mark | +11,708 | - | - |
| 2026-08-15 | Munch Mark | -2,984 | $57.7 | $172,177 |
| 2026-08-15 | Munch Mark | +14,443 | - | - |
| 2026-08-15 | Herman Gerald N | +12,803 | - | - |
| 2026-08-15 | Herman Gerald N | -2,724 | $57.7 | $157,175 |
| 2026-08-15 | Herman Gerald N | +15,794 | - | - |
| 2026-08-15 | LAUKIEN FRANK H | +71,651 | - | - |
| 2026-08-15 | LAUKIEN FRANK H | -4,760 | $57.7 | $274,652 |
| 2026-08-15 | LAUKIEN FRANK H | +29,463 | - | - |
| 2026-08-14 | Munch Mark | -2,000 | - | - |
| 2026-08-14 | Munch Mark | -2,000 | $57.6 | $115,200 |
| 2026-08-14 | Munch Mark | +2,000 | $22.19 | $44,380 |
| 2026-08-11 | Munch Mark | -1,619 | $57.02 | $92,315 |
| 2026-08-11 | Herman Gerald N | -1,410 | $57.02 | $80,398 |
| 2026-08-11 | LAUKIEN FRANK H | -4,838 | $57.02 | $275,863 |
| 2026-08-10 | Munch Mark | -1,573 | $56.32 | $88,591 |
| 2026-08-10 | Herman Gerald N | -1,289 | $56.32 | $72,596 |
| 2026-08-10 | LAUKIEN FRANK H | -4,564 | $56.32 | $257,044 |
| 2026-08-09 | Munch Mark | -1,904 | $53.41 | $101,693 |
| 2026-08-09 | Herman Gerald N | -1,600 | $53.41 | $85,456 |
| 2026-08-09 | LAUKIEN FRANK H | -2,361 | $53.41 | $126,101 |
| 2026-07-15 | Munch Mark | -2,000 | - | - |
| 2026-07-15 | Munch Mark | -2,000 | $60.25 | $120,500 |
| 2026-07-15 | Munch Mark | +2,000 | $22.19 | $44,380 |
| 2026-06-15 | Munch Mark | -2,000 | - | - |
| 2026-06-15 | Munch Mark | -2,000 | $54.76 | $109,520 |
| 2026-06-15 | Munch Mark | +2,000 | $22.19 | $44,380 |
| 2026-05-15 | Bernard Thierry | +2,886 | - | - |
| 2026-05-15 | Munch Mark | -2,000 | - | - |
| 2026-05-15 | Munch Mark | -2,000 | $43.9 | $87,800 |
| 2026-05-15 | Munch Mark | +2,000 | $22.19 | $44,380 |
| 2026-04-15 | Munch Mark | -2,000 | - | - |
| 2026-04-15 | Munch Mark | -2,000 | $39.9 | $79,800 |
| 2026-04-15 | Munch Mark | +2,000 | $22.19 | $44,380 |
| 2026-03-13 | Munch Mark | -2,000 | - | - |
| 2026-03-13 | Munch Mark | -2,000 | $35.44 | $70,880 |
| 2026-03-13 | Munch Mark | +2,000 | $22.19 | $44,380 |
| 2026-02-15 | Bures Thomas | -274 | $36.51 | $10,004 |
| 2026-02-15 | Phillips Jack | +4,520 | - | - |
| 2026-02-15 | Friend Cynthia M | +4,520 | - | - |
| 2026-02-15 | Requardt Hermann Fritz | +4,520 | - | - |
| 2026-02-15 | Anderson Bonnie H | +4,520 | - | - |
| 2026-02-15 | Perkins Adelene Q | +4,520 | - | - |
| 2026-02-15 | LINTON WILLIAM A | +4,520 | - | - |
| 2026-02-15 | PACKER RICHARD A | +4,520 | - | - |
| 2026-02-15 | ROSENTHAL BOB | +4,520 | - | - |
| 2026-02-15 | ORNELL JOHN A | +4,520 | - | - |
| 2026-02-15 | FRANCIS LAURA | +4,520 | - | - |
| 2026-02-13 | Munch Mark | -2,000 | - | - |
| 2026-02-13 | Munch Mark | -2,000 | $36.94 | $73,880 |
| 2026-02-13 | Munch Mark | +2,000 | $22.19 | $44,380 |
| 2026-01-15 | Munch Mark | -2,000 | - | - |
| 2026-01-15 | Munch Mark | -2,000 | $49.2 | $98,400 |
| 2026-01-15 | Munch Mark | +2,000 | $22.19 | $44,380 |
| 2026-01-12 | Munch Mark | -7,000 | - | - |
| 2026-01-12 | Munch Mark | -7,000 | $55 | $385,000 |
| 2026-01-12 | Munch Mark | +7,000 | $22.19 | $155,330 |
| 2026-01-05 | Munch Mark | -15,337 | - | - |
| 2026-01-05 | Munch Mark | -14,000 | - | - |
| 2026-01-05 | Munch Mark | -4,506 | - | - |
| 2026-01-05 | Munch Mark | -15,337 | $49.25 | $755,347 |
| 2026-01-05 | Munch Mark | -14,000 | $50 | $700,000 |
| 2026-01-05 | Munch Mark | -4,506 | $50 | $225,300 |
| 2026-01-05 | Munch Mark | +15,337 | $22.19 | $340,328 |
| 2026-01-05 | Munch Mark | +14,000 | $22.19 | $310,660 |
| 2026-01-05 | Munch Mark | +4,506 | $22.19 | $99,988 |
| 2025-12-01 | PACKER RICHARD A | -10,000 | - | - |
| 2025-12-01 | PACKER RICHARD A | -5,028 | $48.375 | $243,230 |
| 2025-12-01 | PACKER RICHARD A | +10,000 | $24 | $240,000 |
| 2025-11-06 | ORNELL JOHN A | +10,000 | - | - |
| 2025-11-06 | ORNELL JOHN A | -6,233 | $39 | $243,087 |
| 2025-11-06 | ORNELL JOHN A | +10,000 | $24 | $240,000 |